Skip to content
Screener

Total Equity at other companies

ResMed logo
ResMedRMD
$6.59B+10.3%
LivaNova logo
LivaNovaLIVN
$1.33B+18.0%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$429.18M-6.4%
Neuropace, Inc. logo
Neuropace, Inc.NPCE
$14.45M-40.4%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
$18.84M-5.7%
Globus Medical logo
Globus MedicalGMED
$4.77B+11.0%

Other financials

Income statement

See full
Revenue$204.6M+1.6%
Gross profit$176.9M+3.7%
Operating income-$1.1M+24.7%
Net income-$11.3M-477%
EPS (diluted)-$0.39-490%

Balance sheet

See full
Cash & equivalents$98.9M+83.6%
Total debt$29.6M-11.8%
Total assets$911.4M+24.7%

Cash flow

See full
Operating cash flow$12.8M+292%
CapEx$9.7M+15.7%
Free cash flow$3.1M+121%

Valuation

See full
Market cap$1.7B-26.6%
Enterprise value$1.63B-27.3%
P/E13×-30.7×
P/S1.9×-0.8×

Profitability

See full
Gross margin85.8%+1.1pp
Operating margin5.6%-0.3pp
Net margin14.3%+6.4pp
FCF margin10.6%+1.2pp

Returns & leverage

See full
Return on equity18.4%+7.5pp
Debt / equity0.0×
Current ratio6.3×-2.7×

Where this comes from

Reported directly by Inspire Medical Systems in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The source filing: Inspire Medical Systems’s 10-Q, filed May 4, 2026.

Filed
May 4, 2026, 4:07 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001609550-26-000023
Line itemMarch 31, 2026December 31, 2025
Stockholders' equity:
Preferred Stock, $0.001 par value; 10,000,000 shares authorized; no shares issued and outstanding
Common Stock, $0.001 par value; 200,000,000 shares authorized; 28,802,039 and 28,579,015 issued and outstanding at March 31, 2026 and December 31, 2025, respectively2929
Additional paid-in capital950,449927,159
Accumulated other comprehensive (loss) income(352)464
Accumulated deficit(157,786)(146,492)
Total stockholders' equity792,340781,160
Total liabilities and stockholders' equity$911,376$907,317

Item 1. Financial Statements.

FAQ

What is Inspire Medical Systems's total equity?
Inspire Medical Systems (INSP) reported total equity of $792.34M in Q1 2026.
How has Inspire Medical Systems's total equity changed year-over-year?
Inspire Medical Systems's total equity increased by 24.6% year-over-year, from $635.74M to $792.34M.
What is the long-term trend for Inspire Medical Systems's total equity?
Over 5 years (2020 to 2025), Inspire Medical Systems's total equity has grown at a 27.7% compound annual growth rate (CAGR), from $229.75M to $781.16M.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.

Ask your AI about Inspire Medical Systems's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude